These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21918983)

  • 1. Immunogenicity of recombinant human interferon beta interacting with particles of glass, metal, and polystyrene.
    Van Beers MM; Gilli F; Schellekens H; Randolph TW; Jiskoot W
    J Pharm Sci; 2012 Jan; 101(1):187-99. PubMed ID: 21918983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice.
    van Beers MM; Sauerborn M; Gilli F; Brinks V; Schellekens H; Jiskoot W
    Pharm Res; 2011 Oct; 28(10):2393-402. PubMed ID: 21544687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta.
    van Beers MM; Sauerborn M; Gilli F; Hermeling S; Brinks V; Schellekens H; Jiskoot W
    J Immunol Methods; 2010 Jan; 352(1-2):32-7. PubMed ID: 19857496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of Recombinant Human Interferon Beta-1b in Immune-Tolerant Transgenic Mice Corresponds with the Biophysical Characteristics of Aggregates.
    Abdolvahab MH; Fazeli A; Halim A; Sediq AS; Fazeli MR; Schellekens H
    J Interferon Cytokine Res; 2016 Apr; 36(4):247-57. PubMed ID: 26835734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of ADA against recombinant human interferon beta in immune tolerant mice requires rapid recruitment of CD4⁺ T cells, induces formation of germinal centers but lacks susceptibility for (most) adjuvants.
    Kijanka G; Sauerborn M; Boon L; Schellekens H; Brinks V
    J Pharm Sci; 2015 Feb; 104(2):396-406. PubMed ID: 25219665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified immune tolerant mouse model to study the immunogenicity of recombinant human interferon beta.
    Abdolvahab MH; Brinks V; Schellekens H
    J Immunol Methods; 2014 Dec; 415():17-23. PubMed ID: 25450255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregated recombinant human interferon Beta induces antibodies but no memory in immune-tolerant transgenic mice.
    van Beers MM; Sauerborn M; Gilli F; Brinks V; Schellekens H; Jiskoot W
    Pharm Res; 2010 Sep; 27(9):1812-24. PubMed ID: 20499141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a transgenic mouse model immune tolerant for human interferon Beta.
    Hermeling S; Jiskoot W; Crommelin D; Bornaes C; Schellekens H
    Pharm Res; 2005 Jun; 22(6):847-51. PubMed ID: 15948027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody interactions with micro- and nanoparticles: adsorption, aggregation, and accelerated stress studies.
    Bee JS; Chiu D; Sawicki S; Stevenson JL; Chatterjee K; Freund E; Carpenter JF; Randolph TW
    J Pharm Sci; 2009 Sep; 98(9):3218-38. PubMed ID: 19492408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polystyrene film-coated glassware: a new means of reducing metal losses in trace metal speciation.
    Pinheiro JP; Bosker W
    Anal Bioanal Chem; 2004 Dec; 380(7-8):964-8. PubMed ID: 15568138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shear-flow induced detachment of Saccharomyces cerevisiae from stainless steel: influence of yeast and solid surface properties.
    Guillemot G; Vaca-Medina G; Martin-Yken H; Vernhet A; Schmitz P; Mercier-Bonin M
    Colloids Surf B Biointerfaces; 2006 May; 49(2):126-35. PubMed ID: 16621474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory.
    Sauerborn M; van Beers MM; Jiskoot W; Kijanka GM; Boon L; Schellekens H; Brinks V
    J Clin Immunol; 2013 Jan; 33(1):255-63. PubMed ID: 22945588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-associated water and secondary structure effect removal of blood proteins from metallic substrates.
    Anand G; Zhang F; Linhardt RJ; Belfort G
    Langmuir; 2011 Mar; 27(5):1830-6. PubMed ID: 21182242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on the interaction of proteins with a polydimethylsiloxane elastomer. I. Monolayer protein capture capacity (PCC) as a function of protein pl, buffer pH and buffer ionic strength.
    Butler JE; Lü EP; Navarro P; Christiansen B
    J Mol Recognit; 1997; 10(1):36-51. PubMed ID: 9179778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a transgenic mouse model to study the immunogenicity of recombinant human insulin.
    Torosantucci R; Brinks V; Kijanka G; Halim LA; Sauerborn M; Schellekens H; Jiskoot W
    J Pharm Sci; 2014 May; 103(5):1367-74. PubMed ID: 24619587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive adsorption of fibrinogen and albumin and blood platelet adhesion on surfaces modified with nanoparticles and/or PEO.
    Nonckreman CJ; Fleith S; Rouxhet PG; Dupont-Gillain CC
    Colloids Surf B Biointerfaces; 2010 Jun; 77(2):139-49. PubMed ID: 20171850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of carboxyl groups on the adsorption behavior of low-molecular-weight substances on a stainless steel surface.
    Nagayasu T; Yoshioka C; Imamura K; Nakanishi K
    J Colloid Interface Sci; 2004 Nov; 279(2):296-306. PubMed ID: 15464793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal buffer systems for a newly glycosylated recombinant human interferon-β with biophysical stability and DoE approaches.
    Kim NA; Song K; Lim DG; Hada S; Shin YK; Shin S; Jeong SH
    Eur J Pharm Sci; 2015 Oct; 78():177-89. PubMed ID: 26215462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution behavior of IFN-beta-1a: an empirical phase diagram based approach.
    Fan H; Ralston J; Dibiase M; Faulkner E; Middaugh CR
    J Pharm Sci; 2005 Sep; 94(9):1893-911. PubMed ID: 16052555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.